en

PRODUCT DETAIL

Bupivacaine Noridem 2,5 mg/ml injekčný roztok

Code 6913D
MA number 01/0068/21-S
Product Form: sol inj 50x20ml/50 mg (amp.PP v blistri)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Noridem Enterprises Ltd., Cyprus
Therapeutic Class: 01 - ANAESTHETICA (LOKÁLNE)
ATC:
N NERVOUS SYSTEM
N01 ANESTHETICS
N01B ANESTHETICS, LOCAL
N01BB Amides
N01BB01 Bupivacaine
Shelf life: 24
Container: ampoule PP
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 28.04.2021
Validity: 28.04.2026
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Bupivacaine Noridem 02_2022.pdf  
PIL: PIL_Bupivacaine Noridem_02_2022.pdf  
Safety feature Yes
Data update: 12.05.2021
eu-flag.png sk-flag.png